Michael Schubert (@_ms03) header
Michael Schubert (@_ms03) profile picture

👨‍🔬🧬 using 🧫 & 💻 to study how cells go rogue at @NKI_nl • Previously @EMBLEBI, PhD from @Cambridge_Uni • #cancer #aneuploidy #omics #rstats, dash of #hpc

Amsterdam, Nederland
Joined August 2014
Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)Photo by Michael Schubert (@_ms03)
Michael Schubert retweeted
Ralph Baric and Ian Lipkin in the NYT raising the alarm on a new Cell paper where Wuhan Institute of Virology scientists experiment on ANOTHER coronavirus that can infect humans under grossly inadequate biosafety precautions. “could have significant risks for people worldwide.”
81
312
128
1,318
427,361
📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info: bit.ly/3O4bOjq
1
24
5
34
10,817
Michael Schubert retweeted
I remain of the view that the disengagement of academics from this forum was a hugely self-defeating gesture. It scuttled what had been an unprecedented resource for academic communication and a valuable platform for public outreach.
There are now papers showing that the migration of academic communities from Twitter to other social media sites mostly failed. But they never fully returned to Twitter either. I wonder if we will ever see so many different communities interacting in the same online space again.
16
28
8
224
42,194
"Quitting science", as if industrial research doesn't exist and/or there is shame in putting your *very* expensive degree to work in high level tech support, consultation, contract research, tutoring, entrepreneurship, etc, etc. Weird culty language to say leaving academia, tbh
20
27
330
29,068
Michael Schubert retweeted
Our Review on “Aneuploidy as a driver of human cancer” is out in Nature Genetics. Check it out! 🎉 The Ben-David lab wishes everyone Shana Tova — may the new year be much better than the ending one, bringing peace and stability to all! 🙏 nature.com/articles/s41588-0…
3
46
159
12,656
Michael Schubert retweeted
It's great to see my first paper of the PhD published in @NatureBiotech! go.nature.com/47ARizC. This describes our scRNA-seq method, scITD, for analyzing how the transcriptional states of multiple cell types are linked across patients. A few highlights from the paper:
9
45
228
31,894
Michael Schubert retweeted
Can cells adapt to aneuploidy? Our new study reveals that reducing chromosomal instability and inflammation is key to adaptation. Thanks for everyone that contributed! @_ms03 @marsotordlt @JonneRaaij @MedemaRene embopress.org/doi/full/10.10…
8
30
1,380
Michael Schubert retweeted
When dealing with a complex problem with many unknowns, humility is key. If you think you know what you're doing, you probably don't know what you're doing. Be aware of your own biases & weaknesses, and hedge your potential mistakes. Don't be fooled by confidence -- it's often a mask for ignorance.
23
94
6
667
55,060
Michael Schubert retweeted
Premature abstraction is WAY more prevalent and worse than premature optimization and really handcuffs code bases for years and years.
61
239
39
1,510
197,459
Michael Schubert retweeted
Attention grant reviewers: power analysis is an exercise in box ticking that we can all do without.
Prospective power analysis is hilarious because your replace an arbitrary guess of sample size with an arbitrary guess of the effect size you’ve yet to measure, do a touch of arithmetic, and suddenly it’s considered rigorous
10
22
3
221
51,502
Michael Schubert retweeted
I've always found that the majority of people in the top 1% of whatever they were doing were always the most kind, helpful, and relaxed. The people who were in the middle were the complete opposite.
5
8
2
62
31,239
Michael Schubert retweeted
15
59
48
176
450,315
As a multidisciplinary field, it is hard to be good at bio, programming, stats, maths. For those coming from bio, hurdles were coding, stats & maths. For those coming from CS, understanding concepts in bio (e.g. statistically meaningful != biologically meaningful).
What is your biggest challenge when you started to learn bioinformatics?
2
6
16
4,367
Michael Schubert retweeted
Fantastic ⁦@Nature⁩ by Nir Hacohen &co! They created gene transcription maps at the single cell level for 17 different cell types in the lymph node in response to each of the 86 cytokines & develop a tool to infer from RNAseq data cytokine activity! nature.com/articles/s41586-0…
2
81
5
319
48,878
Michael Schubert retweeted
Accurate Transcription Factor (TF) activity estimation is key to interpret #transcriptomics data 🧬💡 In collaboration with @NTNU and @BSC_CNS, we present a high-confidence collection of signed regulons for >1000 TFs: academic.oup.com/nar/advance…, now peer-reviewed @NAR_open 🧵⬇️
1
67
4
201
37,797
Michael Schubert retweeted
If you take a look at some real challenging datasets like Chain-of-Thought Hub, you will see how large the gap between small models vs large ones github.com/FranxYao/chain-of… Again, pushing forward open source is awesome, but one should be honest to themselves.
The False Promise of Imitating Proprietary LLMs Open-sourced LLMs are adept at mimicking ChatGPT’s style but not its factuality. There exists a substantial capabilities gap, which requires better base LM. arxiv.org/abs/2305.15717
10
59
10
345
104,399
🚨 Delighted to share our back-to-back publications in @Nature (nature.com/articles/s41586-0…) and @NatureGenetics (nature.com/articles/s41588-0…)🚨. In these publications we unravel the pan-cancer immunogenomics differences between primary and metastatic tumors. Thread below🧵👇
29
149
14
549
118,822